|
||||||||||||||||||||||||||||||
 |
Welcome to the 5th annual |
|
|
| 2 -3 December 2008, Brussels, Belgium | ||
The biopharmaceutical market is at a pivotal and a potentially challenging point of its evolution. A predicted half of all products on the global pharma market will be biologics by the year 2010 and by 2020, the pharmaceutical market is anticipated to more than double to €819 billion. In order to claim a share of this lucrative and fast developing market and to keep up with the pace of development it is essential that biopharmaceutical manufacturers keep abreast of the latest developments and technologies, not only from a technical and operational perspective, but also from a regulatory point of view. VIB Events 5th annual Optimising Biomanufacturing Processes conference, being held on 2 & 3 December in Brussels, Belgium, will bring experts from the industry together to discuss the latest developments in biopharmaceutical processes and technology, with a focus on upstream and downstream productivity maximisation, disposable technologies, Quality by Design, biosimilars and regulations. Through a series of presentations and interactive discussions, participants will gain new insight and share hands-on experience in the latest trends and practices in the manufacturing of biopharmaceuticals to ensure they remain successful in this competitive environment. |
